Cargando…

Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) – A study protocol for an open-label, phase II, multicenter study

Radical cystectomy (RC) is recommended for muscle-invasive bladder cancer (MIBC) or highest-risk non-muscle-invasive bladder cancer (NMIBC). Trimodal therapy (TMT) is the most favorable strategy among bladder preservation therapies (BPT) for patients who are ineligible for or refuse RC. However, ref...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sekino, Yuta, Ishikawa, Hitoshi, Kimura, Tomokazu, Kojima, Takahiro, Maruo, Kazushi, Azuma, Haruhito, Yoshida, Ken, Kageyama, Yukio, Ushijima, Hiroki, Tsuzuki, Toyonori, Sakurai, Hideyuki, Nishiyama, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878176/ https://www.ncbi.nlm.nih.gov/pubmed/33615035 http://dx.doi.org/10.1016/j.conctc.2021.100724

Ejemplares similares

Proton beam therapy for muscle-invasive bladder cancer: A systematic review and analysis with Proton-Net, a multicenter prospective patient registry database
por: Araya, Masayuki, et al.
Publicado: (2023)

Antitumour potential of BPT: a dual inhibitor of cdk4 and tubulin polymerization
por: Mahale, S, et al.
Publicado: (2015)

Use of Atezolizumab for Bladder and Non–Small Cell Lung Cancers
por: Moore, Kayla Faith
Publicado: (2017)

A Japanese registry study and systematic review of particle therapy for renal cell carcinoma
por: Ishikawa, Hitoshi, et al.
Publicado: (2023)

News in the classification of WHO 2022 bladder tumors
por: Raspollini, Maria Rosaria, et al.
Publicado: (2023)

New ways to cope with depression—study protocol for a randomized controlled mixed methods trial of bouldering psychotherapy (BPT) and mental model therapy (MMT)
por: Kind, Leona, et al.
Publicado: (2023)

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer
por: Aydin, Ahmet Murat, et al.
Publicado: (2017)

Proton beam therapy for renal pelvis and ureter cancer: A report of 5 cases and a literature review
por: Iizumi, Takashi, et al.
Publicado: (2019)

Efficacy of long-term extended nursing services combined with atezolizumab in patients with bladder cancer after endoscopic bladder resection
por: Song, Yao, et al.
Publicado: (2022)

Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinoma
por: Tsai, Yu-Lun, et al.
Publicado: (2020)

Effects of lymphopenia on survival in proton therapy with chemotherapy for non-small cell lung cancer
por: Nakamura, Masatoshi, et al.
Publicado: (2023)

Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan
por: Oshiro, Yoshiko, et al.
Publicado: (2021)

Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis
por: Sekino, Yuta, et al.
Publicado: (2022)

Bladder Replacement Therapy
por: Liu, Xinqi, et al.
Publicado: (2023)

Long-term complete response in small cell bladder carcinoma treated with carboplatin, etoposide, and atezolizumab
por: Kamitani, Rei, et al.
Publicado: (2022)

Support System of Cystoscopic Diagnosis for Bladder Cancer Based on Artificial Intelligence
por: Ikeda, Atsushi, et al.
Publicado: (2020)

Comparison of reduced field-of-view DWI and full field-of view DWI for the differentiation between non-muscle invasive bladder cancer and muscle invasive bladder cancer using VI-RADS
por: Juri, Hiroshi, et al.
Publicado: (2022)

Atezolizumab for the treatment of advanced recurrent basal cell carcinoma and urothelial carcinoma of bladder: a case report
por: Küronya, Zsófia, et al.
Publicado: (2022)

Superficial Bladder Cancer Therapy
por: Schenkman, Emmanuel, et al.
Publicado: (2004)

Systemic therapy in bladder cancer
por: Pinto, Ian G.
Publicado: (2017)

An Analysis of Vertebral Body Growth after Proton Beam Therapy for Pediatric Cancer
por: Baba, Keiichiro, et al.
Publicado: (2021)

Collagenous colitis and atezolizumab therapy: an atypical case
por: Gallo, Antonella, et al.
Publicado: (2020)

Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft
por: Inamoto, Teruo, et al.
Publicado: (2015)

Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer
por: Iizumi, Takashi, et al.
Publicado: (2021)

Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder.
por: Uchibayashi, T., et al.
Publicado: (1995)

Trimodality Therapy for Bladder Preservation in the Elderly Population with Invasive Bladder Cancer
por: Turgeon, Guy-Anne, et al.
Publicado: (2014)

Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer
por: Rose, Tracy L., et al.
Publicado: (2016)

Optimal Bladder Condition in Volumetric Modulated Arc Therapy for Prostate Cancer: The Role of Superior-Inferior Lengths of the Bladder and Dose Constraints
por: Ishikawa, Yojiro, et al.
Publicado: (2023)

Early Prediction of Response Focused on Tumor Markers in Atezolizumab plus Bevacizumab Therapy for Hepatocellular Carcinoma
por: Tanabe, Norikazu, et al.
Publicado: (2023)

Novel Software-Assisted Hemodynamic Evaluation of Pelvic Flow During Chemoperfusion of Pelvic Arteries for Bladder Cancer: Double- Versus Single-Balloon Technique
por: Yamamoto, Kiyohito, et al.
Publicado: (2016)

Effects of an unsupervised Nordic walking intervention on cognitive and physical function among older women engaging in volunteer activity
por: Nemoto, Yuta, et al.
Publicado: (2021)

Bladder Cancer: Principles of Combination Therapy
por: Read, G.
Publicado: (1982)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Glucocorticoid therapy and risk of bladder cancer
por: Dietrich, K, et al.
Publicado: (2009)

Overactive Bladder: Pathophysiology, Diagnostics, and Therapies
por: Heesakkers, John P. F. A., et al.
Publicado: (2011)

Antiplatelet therapy and bladder tumor resection
por: Goel, Apul, et al.
Publicado: (2018)

Cell Therapies in Bladder Cancer Management
por: Morales, Lucia, et al.
Publicado: (2021)

Advances in Diagnosis and Therapy for Bladder Cancer
por: Hu, Xinzi, et al.
Publicado: (2022)

Strategies to Get Drugs across Bladder Penetrating Barriers for Improving Bladder Cancer Therapy
por: Wang, Shupeng, et al.
Publicado: (2021)

The Effect of Tri-Modality Therapy with Bladder Preservation for Selective Muscle-Invasive Bladder Cancer
por: Zhiyu, Zhang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6sfnlu7pe18qbajsgdhk3kbt9r